Vicarious Surgical, Inc. · OTC:RBOT

Vicarious Surgical — Investor Presentation (August 2024)

22 slides from Vicarious Surgical's investor presentation, August 2024

  1. Slide 1: Investor Presentation August 2024

    INVESTOR PRESENTATION AUGUST 2024

  2. Slide 2: Disclaimer

    DISCLAIMER This presentation includes “forward-looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995. The company’s actual results may differ from its expectations, estimates, and projections and, consequently, yo

  3. Slide 3: Key Investment Highlights

    KEY INVESTMENT HIGHLIGHTS GROWING $150B MARKET THAT IS 96% UNPENETR ATED BY ROBOTIC SURGERY 1 WITH STRONG EXISTING REIMBURSEMENT UNPRECEDENTED PARTNERSHIPS WITH LEADING HEALTHCARE SYSTEMS 2 PROPRIETARY DECOUPLED ACTUATOR TECHNOLOGY ENABLES UNPAR ALLELED FUNCTIONALITY UNIQUE PL ATFORM ARCHITECTURE DE

  4. Slide 4: Surgery Today

    SURGERY TODAY 45 Million 96% 1 $150 Billion Procedures Manual 1 in 3 1 2 INITIAL MARKET OPPORTUNITY: ABDOMINAL ROBOTIC- PROCEDURES HAVE SURGICAL 3 ADDRESSABLE WORLDWIDE COMPLICATIONS PER YEAR • HERNIA • GALLBLADDER • GASTROINTESTINAL ~4% ROBOTIC ADOPTION DUE TO: • GYNECOLOGY • HIGH COST • LIMITED AC

  5. Slide 5: The Vicarious Surgical System

    01 THE VICARIOUS SURGICAL SYSTEM VICARIOUS SURGICAL INVESTOR PRESENTATION AUGUST 2024 5

  6. Slide 6: The System

    THE SYSTEM OUR DECOUPLED TECHNOLOGY UNIQUELY BENEFITS THE PATIENT, SURGEON, AND HOSPITAL OUR PATIENT CART • MINIMALLY INVASIVE VIA 1.8CM SINGLE PORT 1 • ENHANCED DEXTERITY AND EXPANSIVE R ANGE OF MOTION • SHOULDERS, ELBOW, AND WRIST INTR A-ABDOMINAL • 13 DEGREES OF FREEDOM PER ARM (INCLUDING 9 FROM

  7. Slide 7: Decoupled Actuators: Our Enabling Technology

    50x EXISTING SURGICAL DECOUPLED ACTUATORS: ROBOTS IF THEY HAD 5+ DEGREES OF 40x FREEDOM IN THE BODY OUR ENABLING TECHNOLOGY UNWANTED FORCE 30x 20x EXISTING SURGICAL ROBOTS OUR DECOUPLED ADVANTAGE BUILD-UP PROPRIETARY TECHNOLOGY: CABLE BREAKING POINT 1 10x • ISOL ATES CABLE PATHWAYS • REMOVES BUILD U

  8. Slide 8: One Small Incision

    ONE SMALL INCISION 2 COMPLICATION RATES AS A FUNCTION OF INCISION SIZE OBTURATOR UTILIZATION SCALPEL UTILIZATION 1 20% MINIMIZING PATIENT COMPLICATIONS THROUGH 1.8CM TROCAR OPEN SURGERY • <2.0CM INCISION ABILITY TO UTILIZE OBTUR ATOR • >2.0CM INCISION REQUIRES SCALPEL • OBTUR ATOR DRIVES COMPLICATIO

  9. Slide 9: Unrestricted Surgeon Workspace

    UNRESTRICTED SURGEON LEGACY SYSTEMS HAVE LIMITED WORKSPACE WORKING AREA NEARLY 360° WORKSPACE IN THE ABDOMEN THROUGH ONE 1.8CM 1 TROCAR THE 13 DEGREES OF FREEDOM POWERED BY PROPRIETARY DECOUPLED MOTION PROVIDES SURGEONS UNPRECEDENTED DEXTERITY AND R ANGE OF MOTION COLLISIONS INSIDE AND OUTSIDE THE P

  10. Slide 10: Sensing and Visualization

    SENSING AND VISUALIZATION DECOUPLED ACTUATORS ENABLE UNPRECEDENTED COLLECTING HIGH QUALITY DATA: THE KEY TO ENABLE SURGEON DECISION SUPPORT, MACHINE LEARNING, AND BROADER AI CAPABILITY 1 FUNTIONALITY INCLUDING: MEASUREMENT OF FORCE AND POSITION WITH SENSORS FROM WITHIN ABDOMINAL CAVITY AUTOMATED TIS

  11. Slide 11: Attractive Cost Model

    ATTRACTIVE COST MODEL ADVANCED ENGINEERING ENABLES COMPETITIVE COST ADVANTAGE ON BOTH CAPITAL EQUIPMENT AND INSTRUMENTS CAPITAL EQUIPMENT INSTRUMENTS • Decoupled actuators enable high force capability and excellent dexterity with polymer cables • Capital equipment is primarily non-robotic as movemen

  12. Slide 12: Future of Surgery

    02 FUTURE OF SURGERY VICARIOUS SURGICAL INVESTOR PRESENTATION AUGUST 2024 12

  13. Slide 13: Transforming Robotics to Become the Standard of Care

    TRANSFORMING ROBOTICS TO AUTOMATED PATIENT BECOME THE STANDARD OF CARE PROTECTION 2 THE VICARIOUS SURGICAL PLATFORM IS DESIGNED TO REDUCE SURGICAL THE FUTURE WE ARE BUILDING COMPLICATIONS, CURRENTLY 1 IN 3 TODAY 1 LESS INVASIVE UNRESTRICTED DEXTERITY AND ACCESS REDUCED ERRORS AND ACCIDENTS By alerti

  14. Slide 14: Building Towards Procedural Automation

    BUILDING TOWARDS PROCEDURAL AUTOMATION UNIQUE SYSTEM CLINICALLY ACTIONABLE PROCEDURAL ARCHITECTURE RELEVANT DATA INSIGHTS AUTOMATION Decoupled actuators enable Sensing and visualization Utilize unique and high quality Our platform is uniquely unprecedented functionality, provides specific and proced

  15. Slide 15: Pathway to Commercialization

    03 PATHWAY TO COMMERCIALIZATION VICARIOUS SURGICAL INVESTOR PRESENTATION AUGUST 2024 15

  16. Slide 16: Hospital System Partners

    HOSPITAL SYSTEM CREATING THE FOUNDATION FOR A STRONG COMMERICAL LAUNCH PARTNERS PRODUCT DEVELOPMENT Leverage administrative, operational, and clinical feedback KEY PARTNERSHIPS WITH FIVE LEADING HEALTHCARE PROVIDERS to enable design of a system that meets the needs of all stakeholders REPRESENTING O

  17. Slide 17: Addressable Procedures: 45 Million, $150 Billion

    INDICATION STOMACH & INTESTINAL: (5.4M) PATHWAY COLORECTAL: (4.2M) ~15.0M APPENDECTOMIES: (3.8M) GI PROCEDURES 1 (~3.1M US) BARIATRIC: (0.9M) 45 Million PANCREATIC: (0.4M) ESOPHAGEAL: (0.3M) ABDOMINAL PROCEDURES ADDRESSABLE BY VICARIOUS SURGICAL 7 ADDRESSABLE PROCEDURES ~13.8M CHOLECYSTECTOMIES: (10

  18. Slide 18: Our Roadmap

    OUR ROADMAP DEVELOPMENT AND REGULATORY Beta 2 Beta 2 Build Beta 2 Version 1.0 Version 1.0 Build FDA De Novo Design Lock Integrated Demo Day Design Lock Submission Integrated 2022 2023 2024 2025 2026 2027 HCA & UH Intermountain Centers of Simulator UPMC Health First Clinical Launch Partnership Patien

  19. Slide 19: Team and Investors

    04 TEAM AND INVESTORS VICARIOUS SURGICAL INVESTOR PRESENTATION AUGUST 2024 19

  20. Slide 20: Experienced Management Team

    EXPERIENCED MANAGEMENT TEAM CO-FOUNDER, CHIEF EXECUTIVE OFFICER PRESIDENT CHIEF OPERATING OFFICER CO-FOUNDER, CHIEF MEDICAL OFFICER ADAM SACHS RANDY CLARK JOHN MAZZOLA BARRY GREENE CO-FOUNDER, CHIEF TECHNOLOGY OFFICER VP OF PRODUCT DESIGN AND CHIEF FINANCIAL OFFICER COMMERCIALIZATION SAMMY KHALIFA B

  21. Slide 21: Board of Directors and Seasoned Investors

    BOARD OF DIRECTORS SEASONED INVESTORS 1 BOARD DIRECTOR­ BOARD DIRECTOR BOARD DIRECTOR BOARD DIRECTOR DAVID HO SAMMY KHALIFA ADAM SACHS RIC FULOP Noted HIV/AIDS Researcher; Time “Man of the Year” 1996 Bill Gates BOARD DIRECTOR BOARD DIRECTOR BOARD DIRECTOR VICTORIA DONALD TANG BEVERLY HUSS CARR-BREND

  22. Slide 22: Thank You

    THANK YOU VICARIOUS SURGICAL 78 Fourth Avenue vicarioussurgical.com Waltham, MA, 02451 +1.617.868.1700 VICARIOUS SURGICAL INVESTOR PRESENTATION AUGUST 2024 22

Vicarious Surgical — Investor Presentation (August 2024) on 6ix